AR047486A1 - Derivados de indolizina1,2,3,6,7,8, substituida, inhibidores de los fgfs, su procedimiento de preparacion y composiciones farmaceuticas que los contienen - Google Patents
Derivados de indolizina1,2,3,6,7,8, substituida, inhibidores de los fgfs, su procedimiento de preparacion y composiciones farmaceuticas que los contienenInfo
- Publication number
- AR047486A1 AR047486A1 ARP040103342A ARP040103342A AR047486A1 AR 047486 A1 AR047486 A1 AR 047486A1 AR P040103342 A ARP040103342 A AR P040103342A AR P040103342 A ARP040103342 A AR P040103342A AR 047486 A1 AR047486 A1 AR 047486A1
- Authority
- AR
- Argentina
- Prior art keywords
- radical
- radicals
- atom
- alk
- several
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Immunology (AREA)
- Child & Adolescent Psychology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Reivindicacion 1: Derivados de indolizina de formula (1), caracterizados porque R en las posiciones 6, 7 u8 de la indolizina representa un átomo de H, un átomo de halogeno, un radical metilo, un radical hidroxi, un radical alcoxi lineal o ramificado de 1 a 5 átomos de C, un radical carboxi, un radical alcoxicarbonilo de 2 a 6 átomos de C o un radical de formula: -NR5R6, -NH-SO2-Alk, -NH-CO-Alk, -NH-CO2-Alk, -O-Alk-COOR7, -O-Alk-NR5R6, -O-(CH2)n-Ph, -CO-NR5R6, donde Alk representa un radical alquilo o un radical alquileno lineal o ramificado C1-5, n representa un numero entero de 0 a 5; R5 y R6 idénticos o diferentes representan, cada uno, un átomo de H, un radical alquilo lineal o ramificado C1-5 o un radical bencilo; R7 representa un átomo de H o un radical alquilo C1-5; Ph representa un radical fenilo eventualmente sustituido por uno o varios átomos de halogeno, por uno o varios radicales alcoxi C1-5, por uno o varios radicales carboxi o por uno o varios radicales alcoxicarbonilo C2-6; R1 representa un radical alcoxi lineal o ramificado de C1-5, un radical carboxi, un radical alcoxicarbonilo de C2-6, un radical fenilo eventualmente sustituido por uno o varios átomos de halogeno, por uno o varios radicales alcoxi de C1-5, por uno o varios radicales carboxi o por uno o varios radicales alcoxicarbonilo de C2-6, un radical heteroarilo de 5 eslabones que presentan un heteroátomo elegido entre un átomo de S, o un átomo de O, o un átomo de N que presenta, eventualmente, un segundo átomo de N y que está eventualmente sustituido por uno o varios átomos de halogeno, por uno o varios radicales alquilo lineales o ramificados de C1-5, por uno o varios radicales alcoxi de C1-5, por uno o varios radicales carboxi o por uno o varios radicales alcoxicarbonilo de C2-6, o un radical heteroarilo de 6 eslabones que presenta 1 a 2 átomos de N y que puede ser eventualmente sustituido por uno o varios átomos de halogeno, por uno o varios radicales alquilo, lineales o ramificados de C1-5, por uno o varios radicales alcoxi de C1-5, por uno o varios radicales carboxi o por uno o varios radicales alcoxicarbonilo de C2-6; R2 representa un radical alquilo de C1-5, un radical cicloalquilo de C3-6 o un radical fenilo, eventualmente sustituido por uno o varios átomos de halogeno, por uno o varios radicales alcoxi de C1-5; R3 y R4 idénticos o diferentes representan, cada uno, un radical hidroxi, un radical alcoxi de C1-5, un radical amino, un radical carboxi, un radical alcoxicarbonilo de C2-6, un radical nitro, o un radical de formula: -NR5R6, -NH-CO-Alk, -NH-CO-CF3, -CO-NR5R6, -CO-NHOH donde Alk, R5 y R6 tienen la significacion dada precedentemente para R; a condicion, no obstante, de que cuando R representa un átomo de , R1 no represente un radical alcoxi lineal o ramificado de C1-5, un radical carboxi, o un radical alcoxicarbonilo de C2-6, salvo en el caso en que R3 o R4 representen un radical -CO-NR5R6 o un radical -CO-NHOH, eventualmente, en forma de una de sus sales farmacéuticamente aceptables.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0310957A FR2859997B1 (fr) | 2003-09-18 | 2003-09-18 | Nouveaux derives d'indolizine 1,2,3,6,7,8 substituee, inhibiteurs des fgfs, leur procede de preparation et les compositions pharmaceutiques les contenant. |
Publications (1)
Publication Number | Publication Date |
---|---|
AR047486A1 true AR047486A1 (es) | 2006-01-25 |
Family
ID=34224325
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP040103342A AR047486A1 (es) | 2003-09-18 | 2004-09-17 | Derivados de indolizina1,2,3,6,7,8, substituida, inhibidores de los fgfs, su procedimiento de preparacion y composiciones farmaceuticas que los contienen |
Country Status (7)
Country | Link |
---|---|
US (1) | US7553845B2 (es) |
EP (1) | EP1664047A1 (es) |
JP (1) | JP4943150B2 (es) |
AR (1) | AR047486A1 (es) |
FR (1) | FR2859997B1 (es) |
TW (1) | TW200519113A (es) |
WO (1) | WO2005028476A1 (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2838123B1 (fr) * | 2002-04-04 | 2005-06-10 | Sanofi Synthelabo | Nouveaux derives d'indolozine-1,2,3 substituee, inhibiteurs selectifs du b-fgf |
FR2896247B1 (fr) * | 2006-01-13 | 2008-02-29 | Sanofi Aventis Sa | Composes dimeres agonistes des recepteurs des fgfs (fgfrs), leur procede de preparation et leur application en therapeutique |
EP1891955A1 (en) * | 2006-07-24 | 2008-02-27 | Sanofi-Aventis | Use of 1,2,3-substituted indolizine derivatives, inhibitors of FGFs, for the preparation of a medicament intended for the treatment of degenerative joint diseases |
EP2331541B1 (en) * | 2008-09-04 | 2015-04-22 | Boehringer Ingelheim International GmbH | Indolizine inhibitors of leukotriene production |
WO2010108503A1 (en) | 2009-03-24 | 2010-09-30 | Life & Brain Gmbh | Promotion of neuronal integration in neural stem cell grafts |
CN101648953B (zh) * | 2009-09-24 | 2012-09-05 | 绍兴文理学院 | 一种咪唑并[1,2-b]吡咯并[1,2-f]哒嗪衍生物及其制备方法和用途 |
FR2962437B1 (fr) * | 2010-07-06 | 2012-08-17 | Sanofi Aventis | Derives d'imidazopyridine, leur procede de preparation et leur application en therapeutique |
FR2962438B1 (fr) | 2010-07-06 | 2012-08-17 | Sanofi Aventis | Derives d'indolizines, procedes de preparation et application en therapeutique |
FR2967412B1 (fr) * | 2010-11-17 | 2012-12-14 | Sanofi Aventis | Nouveaux derives d'indolizine, leur preparation et leur application en therapeutique |
FR2985185B1 (fr) | 2012-01-04 | 2013-12-27 | Sanofi Sa | Utilisation en therapeutique de derives d'imidazopyridine |
EP2789619A1 (en) | 2013-04-12 | 2014-10-15 | Kemotech S.r.l. | Pharmaceutical compounds wiht angiogenesis inbhibitory activity |
ITMI20130602A1 (it) * | 2013-04-12 | 2014-10-13 | Kemotech S R L | Composti farmaceutici |
CN108864083B (zh) * | 2018-06-07 | 2021-05-25 | 广东药科大学 | 一类具有抗癌活性的氨基取代吲嗪类化合物及其衍生物 |
CN110251513A (zh) * | 2019-07-03 | 2019-09-20 | 南京大学 | 一种含吡唑的中氮茚化合物在制备抗肿瘤药物中的应用 |
KR102466750B1 (ko) * | 2020-10-23 | 2022-11-15 | 아주대학교산학협력단 | 인돌리진 유도체를 유효성분으로 포함하는 인터페론 유전자 자극제 조성물 |
WO2023057394A1 (en) * | 2021-10-04 | 2023-04-13 | Forx Therapeutics Ag | N,n-dimethyl-4-(7-(n-(1-methylcyclopropyl)sulfamoyl)-imidazo[1,5-a]pyridin-5-yl)piperazine-1-carboxamide derivatives and the corresponding pyrazolo[1,5-a]pyridine derivatives as parg inhibitors for the treatment of cancer |
US11976066B1 (en) | 2023-10-23 | 2024-05-07 | King Faisal University | Substituted 7-amino-3-(substituted benzoyl)indolizine-1-carboxylates as anti-tubercular agents |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ193926A (en) * | 1979-07-06 | 1984-05-31 | Labaz Sanofi Nv | 2-(alkyl or phenyl)-3(4-hydroxybenzoyl)indolizines |
US4378362A (en) * | 1979-12-06 | 1983-03-29 | S.A. Labaz N.V. | Indolizine derivatives and process for preparing the same |
FR2528845A1 (fr) * | 1982-06-17 | 1983-12-23 | Sanofi Sa | Nouveaux derives d'indolizine, leur procede de preparation ainsi que les compositions therapeutiques les contenant |
FR2665444B1 (fr) * | 1990-08-06 | 1992-11-27 | Sanofi Sa | Derives d'amino-benzofuranne, benzothiophene ou indole, leur procede de preparation ainsi que les compositions les contenant. |
WO2002098876A1 (en) * | 2001-06-06 | 2002-12-12 | Vertex Pharmaceuticals Incorporated | Cak inhibitors and uses thereof |
FR2838123B1 (fr) * | 2002-04-04 | 2005-06-10 | Sanofi Synthelabo | Nouveaux derives d'indolozine-1,2,3 substituee, inhibiteurs selectifs du b-fgf |
JP4300928B2 (ja) * | 2003-08-01 | 2009-07-22 | パナソニック株式会社 | 洗濯機 |
-
2003
- 2003-09-18 FR FR0310957A patent/FR2859997B1/fr not_active Expired - Fee Related
-
2004
- 2004-09-16 JP JP2006526664A patent/JP4943150B2/ja not_active Expired - Fee Related
- 2004-09-16 EP EP04787388A patent/EP1664047A1/fr not_active Withdrawn
- 2004-09-16 WO PCT/FR2004/002347 patent/WO2005028476A1/fr active Application Filing
- 2004-09-17 TW TW093128233A patent/TW200519113A/zh unknown
- 2004-09-17 AR ARP040103342A patent/AR047486A1/es unknown
-
2006
- 2006-03-17 US US11/378,972 patent/US7553845B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
FR2859997A1 (fr) | 2005-03-25 |
EP1664047A1 (fr) | 2006-06-07 |
US7553845B2 (en) | 2009-06-30 |
WO2005028476A1 (fr) | 2005-03-31 |
JP2007505867A (ja) | 2007-03-15 |
FR2859997B1 (fr) | 2006-02-03 |
TW200519113A (en) | 2005-06-16 |
JP4943150B2 (ja) | 2012-05-30 |
US20060199962A1 (en) | 2006-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR047486A1 (es) | Derivados de indolizina1,2,3,6,7,8, substituida, inhibidores de los fgfs, su procedimiento de preparacion y composiciones farmaceuticas que los contienen | |
ES2528451T3 (es) | Inhibidores de esfingosina cinasa | |
AR025386A1 (es) | Moduladores de los receptores activados del proliferador de peroxisomas | |
DK1682138T3 (da) | Heterocykliske inhibitorer af MEK | |
AR057712A1 (es) | Dihidropteridinonas en el tratamiento de enfermedades respiratorias | |
NI200800247A (es) | Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparacion y las composiciones farmacéuticas que las contienen. | |
AR055620A1 (es) | Derivados de cicloalcano-carboxamidas | |
AR084768A1 (es) | Moduladores de la senda de complemento y usos de los mismos | |
AR042941A1 (es) | Derivados de tiazol, su preparacion, composiciones farmaceuticas que los contienen y su uso en la fabricacion de medicamentos inhibidores de la proteina-1 de adhesion vascular (vap-1) | |
CY1108522T1 (el) | Μεθοδος συνθεσης της περινδοπριλης και των φαρμακευτικως αποδεκτων αλατων της | |
AR082826A2 (es) | Inhibidores heterociclicos de mek, composiciones farmaceuticas que los contienen, usos, y metodos de preparacion de los mismos | |
CR11333A (es) | cis-IMIDAZOLINAS QUIRALES | |
CY1112084T1 (el) | Παραγωγα 5-φαινυλθειαζολης και χρηση ως αναστολεις της κινασης ρi3 | |
AR050261A2 (es) | Aminoacidos con afinidad por la proteina alfa-2-delta y composiciones farmaceuticas que los contienen y su uso para preparar un medicamento | |
CO5631442A2 (es) | Nuevos derivados de indolizina 1,2,3 sustituida, inhibidores de los fgfs, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
AR065509A1 (es) | Derivados heterociclicos de imidazol, composiciones farmaceuticas que los comprenden y uso de los mismos en trastornos inflamatorios y autoinmunes. | |
AR039689A1 (es) | Difenilazetidinonas sustituidas, medicamentos que comprenden estos compuestos y su uso | |
AR061835A1 (es) | Derivados tetraciclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
UY27979A1 (es) | Indoles sustituidos en posición 2,4 | |
AR063027A1 (es) | Derivados de sulfonamida | |
CY1107028T1 (el) | Παραγωγα ινδανυλ-πιπεραζινων μεθοδος παρασκευης αυτων και οι φαρμακευτικες συνθεσεις που τα περιεχουν | |
AR069781A1 (es) | Compuestos de n-(2,3-dihidro-inden-2-il) propanosulfonamida, composicion farmaceutica que los comprenden y su uso para el tratamiento de la ezquizofrenia. | |
AR043253A1 (es) | 4-[(2,4-dicloro-5-metoxifenil)amino] -6- alcoxi-3-quinolina carbonitrilos para el tratamiento de lesiones isquemicas | |
AR063328A1 (es) | Derivados indolicos su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
AR044275A1 (es) | Uso de derivados de sulfonamidas para la fabricacion de un medicamento para la profilaxis y/o tratamiento de las disfunciones alimentarias |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |